Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...

詳細記述

書誌詳細
主要な著者: Ziad Hijazi, Paolo Verdecchia, Jonas Oldgren, Ulrika Andersson, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Fabio Angeli, John W. Eikelboom, Michael D. Ezekowitz, Stuart J. Connolly, Salim Yusuf, Lars Wallentin
フォーマット: 論文
言語:English
出版事項: Wiley 2019-01-01
シリーズ:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:
atrial fibrillation
biomarker
left ventricular hypertrophy
risk prediction
オンライン･アクセス:https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

インターネット

https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

類似資料